Φορτώνει......
Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients with History of Prior Stroke Plus Diabetes
BACKGROUND AND PURPOSE: Acute ischemic stroke (AIS) patients with history of prior ischemic stroke plus concomitant diabetes mellitus (DM) were excluded from the ECASS III trial due to safety concerns. However, there are few data on use of intravenous tissue plasminogen activator (tPA) and symptomat...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Stroke |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6538420/ https://ncbi.nlm.nih.gov/pubmed/31035901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.024172 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|